Orthofix Medical Inc.
OFIXNasdaqHealthcare · Surgical & Medical Instruments & Apparatus · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $822.3M | $799.5M | $746.6M | $460.7M | $464.5M | $406.6M |
| Operating income | −$81.4M | −$84.6M | −$139.1M | −$13.3M | −$8.3M | −$6.3M |
| Net income | −$92.2M | −$126.0M | −$151.4M | −$19.7M | −$38.4M | $2.5M |
| Total assets | $850.6M | $893.3M | $925.3M | $458.6M | $476.6M | $525.9M |
| Total liabilities | $400.6M | $390.2M | $326.6M | $121.8M | $139.7M | $169.0M |
| Equity | $450.0M | $503.1M | $598.7M | $336.9M | $336.9M | $356.9M |
| EPS (diluted) | $-2.33 | $-3.30 | $-4.12 | $-0.98 | $-1.95 | $0.13 |
| Shares out. | 39.0M | 37.4M | 36.5M | 19.9M | 19.5M | 19.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −9.9%
- Net margin
- −11.2%
- Return on equity
- −20.5%
- Return on assets
- −10.8%
- Return on capital (ROCE)
- −12.0%
- Liabilities / assets
- 47.1%
- Debt / equity
- 0.89×
- Book value / share
- $11.53
- Revenue growth (YoY)
- 2.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 1.02distress
- Accruals / assets
- −14.8%clean
- Beneish M-Score
- -3.22normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 2 warning● 4 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 12, 2015
- NT 10-Kmissed a reporting deadline ↗Mar 17, 2015
- NT 10-Qmissed a reporting deadline ↗Nov 10, 2014
- NT 10-Qmissed a reporting deadline ↗Aug 12, 2014
- NT 10-Kmissed a reporting deadline ↗Mar 18, 2014
- NT 10-Qmissed a reporting deadline ↗Aug 9, 2013
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Juniper Investment Company, LlcActivist (13D)May 27, 2026
- Armistice Capital, LlcPassive (13G)May 15, 2026
- Vanguard Group IncPassive (13G)Mar 27, 2026
- Engine Capital, L.P.Activist (13D)May 8, 2025
- Blackrock, Inc.Passive (13G)Apr 17, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Juniper Investment Company, Llc10% owner | May 22, 2026 | Sell | 242,000 | $10.70 |
| Henneman John B IiiDirector | May 7, 2026 | Buy | 5,000 | $12.26 |
| Engine Capital Management, Lp10% owner | May 5, 2026 | Buy | 110,039 | $11.99 |
| Cedron Jorge AndresOfficer — CLO | Apr 16, 2026 | Sell | 3,743 | $12.82 |
| Vitale LucasOfficer — CP&BOO | Mar 17, 2026 | Sell | 4,269 | $11.92 |
| Capps Vickie LDirector | Mar 9, 2026 | Buy | 2,500 | $12.48 |
| Andrews JulieOfficer — CFO | Mar 4, 2026 | Sell | 2,425 | $12.92 |
| Vitale LucasOfficer — CP&BOO | Mar 4, 2026 | Sell | 1,171 | $12.92 |
| Calafiore MassimoOfficer — President & CEO | Mar 4, 2026 | Sell | 6,189 | $12.92 |
| Fisher PatrickOfficer — President, Global Limb Recon | Mar 4, 2026 | Sell | 778 | $12.92 |
| Mcpherron AvivaOfficer — Pres, Global Ops & Qual | Mar 4, 2026 | Sell | 1,296 | $12.92 |
| Reinhardt MaxOfficer — President, Global Spine | Mar 4, 2026 | Sell | 1,080 | $12.92 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 1.3M | 3.4 | +4.7% |
| Apr 30, 2026 | 1.2M | 5.8 | -7.4% |
| Apr 15, 2026 | 1.3M | 5.4 | +11.5% |
| Mar 31, 2026 | 1.2M | 4.3 | +11.5% |
| Mar 13, 2026 | 1.1M | 3.5 | -2.3% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Regulation FD disclosureMay 21, 2026
- Results of operations · Regulation FD disclosureMay 5, 2026
- Results of operations · Director / officer changeApr 9, 2026
- Results of operations · Regulation FD disclosureFeb 24, 2026
- Results of operations · Regulation FD disclosureNov 4, 2025
- Results of operations · Regulation FD disclosureAug 5, 2025
- Shareholder voteJun 20, 2025
- Results of operations · Regulation FD disclosureMay 6, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4PRIMARY DOCUMENTMay 29, 2026
- 3PRIMARY DOCUMENTMay 29, 2026
- SDMay 29, 2026
- SCHEDULE 13D/AMay 27, 2026
- 8-KMay 21, 2026
- SCHEDULE 13G/AMay 15, 2026
- 4May 8, 2026
- 4OWNERSHIP DOCUMENTMay 7, 2026
- 10-QMay 5, 2026
- 8-KMay 5, 2026
- DEFA14AApr 29, 2026
- DEF 14AApr 29, 2026
- 4Apr 20, 2026
- 8-KApr 9, 2026
- SCHEDULE 13G/AMar 27, 2026